Cytrx reported 51.91K in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Bioline Rx BLRX:US 1.64M 172K
Brainstorm Cell Therapeutics BCLI:US $ 2.86M 324K
Celldex Therapeutics CLDX:US $ 6.91M 670K
Curis CRIS:US $ 5.67M 900K
Cytrx CYTR:US 51.91K 1.93M
Glaxosmithkline GSK:US 2.68B 227M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Karyopharm Therapeutics KPTI:US $ 38.77M 4.21M
Northwest Biotherapeutics NWBO:US 7.87M 1.38M
Novartis NVS:US 3.5B 486M
Seattle Genetics SGEN:US $ 174.22M 36.71M
Takeda 4502:JP 223.43B 7.65B